Raju Sunagar

Genome Valley
Hyderabad, TG, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Development of whole virion inactivated Kyasanur Forest Disease vaccine candidate and its preclinical safety and efficacy evaluation.

Development of whole virion inactivated Kyasanur Forest Disease vaccine candidate and its preclinical safety and efficacy evaluation.

Journal: Frontiers in immunology

Published: January 12, 2026

SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines.

SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines.

Journal: Vaccines

Published: March 16, 2023

Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152).

Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152).

Journal: Frontiers in immunology

Published: October 07, 2022

Preclinical Efficacy of a Trivalent Human FcγRI-Targeted Adjuvant-Free Subunit Mucosal Vaccine against Pulmonary Pneumococcal Infection.

Preclinical Efficacy of a Trivalent Human FcγRI-Targeted Adjuvant-Free Subunit Mucosal Vaccine against Pulmonary Pneumococcal Infection.

Journal: Vaccines

Published: March 05, 2020

Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants.

Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants.

Journal: Frontiers in immunology

Published: March 18, 2019

Evaluation of an outbred mouse model for Francisella tularensis vaccine development and testing.

Evaluation of an outbred mouse model for Francisella tularensis vaccine development and testing.

Journal: PloS one

Published: July 11, 2018

Differential In Vitro Cultivation of Francisella tularensis Influences Live Vaccine Protective Efficacy by Altering the Immune Response.

Differential In Vitro Cultivation of Francisella tularensis Influences Live Vaccine Protective Efficacy by Altering the Immune Response.

Journal: Frontiers in immunology

Published: March 08, 2018

Differential Growth of Francisella tularensis, Which Alters Expression of Virulence Factors, Dominant Antigens, and Surface-Carbohydrate Synthases, Governs the Apparent Virulence of Ft SchuS4 to Immunized Animals.

Differential Growth of Francisella tularensis, Which Alters Expression of Virulence Factors, Dominant Antigens, and Surface-Carbohydrate Synthases, Governs the Apparent Virulence of Ft SchuS4 to Immunized Animals.

Journal: Frontiers in microbiology

Published: January 20, 2017

Differential Cultivation of Francisella tularensis Induces Changes in the Immune Response to and Protective Efficacy of Whole Cell-Based Inactivated Vaccines.

Differential Cultivation of Francisella tularensis Induces Changes in the Immune Response to and Protective Efficacy of Whole Cell-Based Inactivated Vaccines.

Journal: Frontiers in immunology

Published: August 19, 2016

Ex vivo antigen-pulsed PBMCs generate potent and long lasting immunity to infection when administered as a vaccine.

Ex vivo antigen-pulsed PBMCs generate potent and long lasting immunity to infection when administered as a vaccine.

Journal: Vaccine

Published: June 16, 2016

Tularemia vaccine development: paralysis or progress?

Tularemia vaccine development: paralysis or progress?

Journal: Vaccine (Auckland, N.Z.)

Published: May 21, 2016

Prevalence and genotype distribution of methicillin-resistant Staphylococcus aureus (MRSA) in India.

Prevalence and genotype distribution of methicillin-resistant Staphylococcus aureus (MRSA) in India.

Journal: Journal of global antimicrobial resistance

Published: February 04, 2016

Showing 1-12 of 20

Last Updated: 09/26/2026